chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 1, my left arm was very sore progressively into Day 2. My lymph nodes in my neck and collar bone started to swell. The remained swollen for a couple of days, so I made an appt for my doctor to take a look. A week after my vaccine, they were still swollen. The following Wed they were still swollen. I had an ultrasound appt the following Friday. They had gone down by then, but I still had the ultrasound and it was fine. I also had lymph node swelling with the 2nd dose, but it wasn't as bad as the 1st.
I have a hard time sleeping anyway because of my heart condition; I have a hard time sleeping anyway because of my heart condition; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2, BNT162B2 Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose number Unknown, Single for COVID-19 immunization; disopyramide phosphate (NORPACE CR), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication; disopyramide phosphate (NORPACE), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient's medical history and concomitant medications were not reported. On an unspecified date patient experienced  have a hard time sleeping anyway because of my heart condition. The patient stated, I am taking Norpace and Norpace CR, for several years, at the request of my doctor. What I called about 3 days, 4 days ago is, is there any news on Norpace CR which has been discontinued and that is the drug that I take along with the regular Norpace. So what he did was send me 2 Norpace so that I can get up in the middle of the night and take a second one which would be like a continuous release. It is kind of hard because I have a hard time sleeping anyway because of my heart condition. It is highly effective. I just want to get the CR. I do love that drug. It is a life saver. That is the number on the letter but you listen for 10 minutes stories about Pfizer shots, which I have already had. Note: The patient is date of birth/ address was not provided on the phone call. The following information was not confirmed during the call, but retrieved from the system: Reporter phone No. The following information was not provided during the call: Patient gender. The outcome for both events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Seen in our office 8/20 due to 1 day hx of fever and rash approx 4 x 6 cm macular papular rash on immune site (R) thigh. Temp 101. Of not had fever with 2 mo immuz no rash at that time. See today.
Information has been received from a physician concerning a 59 day old male patient who on 14-JUN-2010 was vaccinated with a dose of VAQTA instead of hepatitis B virus vaccine (dose and lot #667261/0261Z). Suspect vaccine included ROTATEQ (date, dose and lot not reported). Other concomitant vaccine included a dose of DTaP, a dose of PREVNAR, a dose of HIB (unspecified carrier) and a dose of poliovirus vaccine and ROTATEQ (dates, doses and lot numbers not reported). The physician reported that was a human error and was not product confusion. No adverse symptoms noted. The patient sought unspecified medical attention. Additional information has been requested.
Vaginal bleeding.  Light spotting the day after vaccine which continued into the next day as well as the wound day which was heavier bleeding.   On day 13 of cycle on the day of vaccination.  Mid cycle spotting/bleeding is highly unusual for me.
Sudden significant blurring of right eye. Loss of depth perception and daily headaches. Condition has not resolved itself.
Fever, bulging fontanelle and fussiness - full inpatient work up (including an LP) was negative and symptoms gradually resolved.
This spontaneous report was received from a registered nurse refers to a 0 month old male patient. On 05-JUN-2014 at 13:43pm (same date that the patient was born) the patient was vaccinated improperly stored dose of RECOMBIVAX HB intramuscular, dose 1, Lot # J012520, Expiration date: 30-JAN-2016 (dose was not reported). No adverse symptoms reported. It was reported that the vaccine storage temperature dropped to 0-1 deg (units not reported) for 18 different episodes according to minimum/maximum. All recorded temperature were within 2-8 deg (units were not reported). This is one of several reports received from the same reporter. Additional information is not expected due to all follow ups requested to complete the case were received.
On the 18th I started Post Menopausal Bleeding, I saw my GYN Dr. and she has take some byopsy  to make sure that nothing else is going on with me. Although I realize many other things could be happening I believe that my symptoms have been happening to many other women and I thought that I should report it as well. I will have an Ultra Sound on 08/31/2022 to determine if what I am dealing with is something related to the vaccine or if there is something else going on with my body.
Palpitations and tachycardia up to 120, elevated BP to 150/80  No other symptoms resolved within 30 minutes
2 days ago she received the pneumococcal 23 valent vaccine to the right deltoid. About 7 hours later she developed pain at the injection site. 10 hours later hours later she developed generalized myalgias. No fever, headache, or nuchal rigidity. Since, the myalgias have improved and she is feeling better. Last night she noted a red rash at the injection site. The injection site remains painful, but is much improved over the day of the injection. No other symptoms. No generalized rash. No GI symptoms.
Information has been received from a health professional concerning a 9 year old female who on 20-APR-2007 was vaccinated with 0.5mL varicella virus vaccine live (Oka/Merck) (Lot# 656287/1508F). On 21-APR-2007, the patient developed swelling, heat and redness in the arm which she was vaccinated. The area affected was 2 to 3 inches in diameter. At the time of this report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. This is one of several reports received from the same source. A lot check has been requested. The records of testing prior to release of the lot in question has been rechecked and found to be satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
No additional symptoms reported; patient received second dose of VARIVAX series that was improperly stored; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, allergies/drug reactions, concurrent conditions and concomitant medications were not reported. On 02-DEC-2019, the patient was vaccinated with second dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, frequency, route of administration, anatomical location were not reported) (lot # S008692 and expiration date: 21-MAR-2021) for prophylaxis. The vaccine was reconstituted using a properly stored sterile diluent.It was reported that the vaccine was exposed to a temperature 6.5 Fahrenheit degrees for 20 minutes. Previous temperature excursion was reported as 8.1Fahrenheit degrees for 25 minutes. It was reported that digital data logger was involved. No additional symptoms reported. No product quality complaints were reported.
Fever 103-104 in 24 hours. Treated with Motrin. Febrile seizure 24 hours later (twice) with hospitalization. Follow up 02/07/05: Fever of 102.5, body shaking, no prior history of seizures.
Information has been received from a physician, for GARDASIL, a Pregnancy Registry product, concerning a 26 year old patient with no significant past medical history and no concurrent medical conditions who was vaccinated with a 0.5 ml dose of GARDASIL on 06-APR-2011 (lot # 666987/1016Z) and a 0.5 ml dose on 22-JUN-2011 (lot # 668260/1570Z) respectively. Concomitant therapy included folic acid, vitamin D and multivitamin. Subsequently, the patient became pregnant. Estimated conception date was 08-JUN-2011. Estimated delivery date was 02-MAR-2012. Date of last menstrual period was approximately 27-MAY-2011. The patient had a dating ultrasound on approximately 19-JUL-2011, at IntraUterine Pregnancy 7 days + 4 weeks. The result was within normal limits. It was reported that the patient had 2 previous pregnancies and 1 full term delivery. No birth defects or infant complications in previous pregnancy. No pre-term deliveries, spontaneous abortions, elective terminations or fetal deaths (stillbirths). The patient developed sinus infection on an unspecified date. In September 2011, the patient started taking erythromycin for the treatment of sinus infection. At the time of reporting, the patient's outcome for sinus infection was unknown. Follow up information has been received from the physician who reported that she did not have access to the patient's medical records any longer, but did recall the outcome of the pregnancy. She reported the patient delivered her baby girl at 32 weeks gestation (in approximately January 2012) via vaginal delivery. The physician did not recall the date of birth or weight of the baby. She could not recall why she went into early labor. However, she stated she saw the patient earlier this summer with her baby. She stated the baby was health with no congenital anomalies and that the baby did quite remarkably post delivery with no residual heart, lung or brain or other organ dysfunctions with the early delivery. That was all the information she could recall. At the time of the report the outcome of early labor was unknown. Upon internal review early labor was considered to be an other important medical event. The child's case is reported in case # 1210USA004750. Additional information is not expected.
Left arm completed swollen, pain/soreness/tenderness unable to move arm without pain. Fatigue fever headache nausea loss of appetite.
Patient reported hive-like rash that started on lower legs that started about 8-12 hours after her first immunization. Over the next few days it spread over about 90% of her body, with the exception of her calves. She was prescribed prednisone and triamcinolone 0.1% cream on 4/5/2021. Rash started to improve after about 1 week of applying triamcinolone twice daily. It took about 3-4 weeks for rash to completely resolve.
I was positive for COVID-19 on 09DEC2022 I had a fever, I had headache, congestion body aches and soreness it felt like I had the flu. I contacted my doctor he prescribed me Paxlovid. It took about 3 days for me to feel better, I was up doing normal thing by the second day.
Patient was given 2 vaccines: Boostrix and Varivax. Boostrix was provided first. Boostrix vaccination resulted in significant bleeding. Patient was anxious from the sight of blood. Varivax vaccine was partially given as the syringe integrity was compromised and vaccine fluid leaked out of needle and syringe junction. Following the removal of needle from patient's arm, patient started to hyperventilate and seize. This lasted for roughly 15 seconds. Patient came to afterwards and had no memory of the incident. Patient stated they felt lightheaded and nauseated. Patient guardian was asked and responded that patient had not eaten anything all day. Patient was given a lollipop. Patient blood sugar was taken and read 82mg/dL. Patient was asked to stay for 15 minutes for observation. Patient was asked to follow up with pediatrician. This is patient's 2nd Varicella dose and had no history of seizures that she can recollect.
Large red rash above elbow on left arm, at injection site and well below.  Larger than the rash after first injection. Warm to the touch.  Appeared morning after shot and lasted five days.  A little itchy.  No trouble, really?just looked big and red.
jaw pain, the jaw getting sore, mainly felt on the right side of the jaw, having pain when even closing the jaw; the jaw being hard to open, having pain when even closing the jaw, and having jaw to pop with movement; Initial information received on 09-Jul-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 40 year old female patient who experienced jaw pain, the jaw was getting sore, mainly felt on the right side of the jaw, the jaw being hard to open, having pain even when closing the jaw and having jaw to pop with movement (pain in jaw and trismus), while she received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Patient had no other vaccine as concomitant medication.  On 30-Jun-2020, the patient received a 0.5 mL booster dose once of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number and Expiry date not reported) via an intramuscular route in the left arm for prophylactic vaccination.  On 01-Jul-2020, the patient had jaw pain, the jaw was getting sore, mainly felt on the right side of the jaw, the jaw being hard to open, having pain even when closing the jaw and having jaw to pop with movement (pain in jaw and trismus) one day following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  It was reported that there had been no change in the jaw pain since it started, that the jaw pain was worse in the morning, that the level of pain with the jaw had stayed consistent, that the more she used the jaw the better she was able to work the jaw and the pain was not as bad.  Other Relevant laboratory test results not provided.  Final diagnosis were pain in jaw and trismus.  The patient was treated with IBUPROFEN for jaw pain and placed heat on that area.  The patient had not recovered from pain in jaw and trismus.  There will be no information available on the batch number for this case.
4:30am symptoms began with moderate chills, headache, nausea, took Tylenol 7am woke up with significant headache even on Tylenol 10:30am as Tylenol was wearing off, very bad body aches all over and chills 1-3pm severe body aches all over and chills; couldn?t help but just cry because everything hurt so badly even on Tylenol, this was awful 3pm took 2 advil because everything hurting so badly was almost unbearable 4pm symptoms lessened on advil 7pm symptoms lessened even with advil wearing off 4/24 morning still feeling a little sore/achey, but better than yesterday, taking Tylenol Meaningful left arm pain also continued both days but that part was expected and consistent with the first shot
Once she received the injection her blood pressure shot up and she had to be rushed to the ER. She was having chest pains and was told she was at stroke level. Having problems with kidneys, heart and lungs. Also she took a whooping cough shot a week before taking the second vaccine.
Patient was COVID-19 vaccine breakthrough case who was hospitalized on 4/23/2021.
Headache that progressed to Migrane with severe Vertigo that lasted 48 hours.
Initial report received from a health care professional on 09 OCTOBER 2014. A 27-year-old female patient had received an intramuscular dose of FLUZONE QIV (lot number and expiry date not reported), in deltoid region on 18 SEPTEMBER 2014. The patient's illness at the time of vaccination and any pre-existing physician diagnosed allergies, birth defects and medical conditions were not reported. On 18 SEPTMBER 2014, i.e. same day after vaccination the patient experienced a burning sensation at the injection site. The patient did not seek medical attention or treatment. It was reported that the pharmacy has been in contact with the patient and the symptoms have resolved. The patient's laboratory investigations were not reported. The patient recovered from the event on an unspecified date. Documents held by sender: none.
Change in menses, more frequent instead of every 28 days about every 21 days, instead of 3-5 days of bleeding, 5-7 days of bleeding, increased pain. Still continuing 11 months later with no improvement.
Information has been received from a lawyer and a consumer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medications were not provided. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX (lot # and route not provided) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2014, a healthcare provider administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In January 2017, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX vaccine, and suffered physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Headache, NauseaVomiting, Pain @ injection site, Chills Narrative:
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a consumer concerned an 18 year old, female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: 20-JUN-2021) dose was 0.5 ml, once total administered on 09-APR-2021 at right arm for prophylactic vaccination. No concomitant medications were reported.  It was reported that, the patient received her vaccine on 09-APR-2021 at an elementary school. Patient was tested on 12-MAY-2021 for antibody and had confirmed immunological vaccine failure. Laboratory data included: SARS-CoV-2 IgG antibody test (NR: not provided) negative (1.49) unspecified unit. The range goes from 20, noting that less than 1 was negative for antibodies. Reporter noted that healthy patient of that ages results should be greater than 20. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). The suspected product quality complaint has been confirmed to be the suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified. based on the PQC evaluation/investigation performed. This case, from the same reporter is linked to 20210535317, 20210534629 and 20210536064. This report was associated with a product quality complaint 90000180000.  Additional information was received from a consumer on 19-MAY-2021 and on 20-MAY-2021.; Sender's Comments: V0: 20210536071-covid-19 vaccine ad26.cov2.s-Confirmed immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
My asthma is usually well controlled. I had Difficultly breathing, asthma attacks after four hours after taking the shot. Needed my rescue inhaler 3 times and I needed the nebulizer later that night. Lung pain in both lungs. I got my shot 03/07/2021. It is 03/16/2021 and I am still having  lung pain and asthma attacks. I am still using my rescue inhaler and nebulizer frequently. I usually never need my nebulizer.   Headaches, Fatigue, and heart palpitations that lasted for 48 hours.
This spontaneous report as received from nurse via a company representative refers to a female patient of unknown age. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date in March 2016, (also reported as unspecified date last week) the patient was vaccinated with first dose of GARDASIL 9 (dosing details were not reported), intramuscularly. The patient was not using any medication concomitantly. On an unknown date in March 2016, 4 minutes after vaccination the patient fainted. The patient was still in the office and needed no follow up medical attention. The patient did not receive any treatment for the event. The outcome of the event was unknown. The reporter did not provide the causality assessment between the event and the suspect therapy. There was no product quality complaint involved. This is one of the two reports received from the same reporter (1604USA010554). Additional information has been requested.
Immediately /p  developed a facial rash, also developed joint pain in the 4th PIP dorsal & mid wrist of rt hand on week post shot.
PROQUAD underwent a temperature excursion and was administered; This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 17-JUN-2021, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T036562 exp date 26-APR-2022) rHA (dose and route not reported) that underwent a temperature excursion. Previous temperature of excursion was 6°F to 14°F (14F) for 2 hours, 14°F to 46°F (45.5F) 1 hour and 30 minutes and 6°F t o14°F (14.4F) for 2 hours.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2106USA006064: US-009507513-2106USA006458: US-009507513-2106USA006459: US-009507513-2106USA006460: US-009507513-2106USA006461: US-009507513-2106USA006462: US-009507513-2106USA006463: US-009507513-2106USA006464: US-009507513-2106USA006465: US-009507513-2106USA006466: US-009507513-2106USA006467: US-009507513-2106USA006468: US-009507513-2106USA006469: US-009507513-2106USA006470: US-009507513-2106USA006471: US-009507513-2106USA006472: US-009507513-2106USA006473: US-009507513-2106USA006474: US-009507513-2106USA006475: US-009507513-2106USA006476: US-009507513-2106USA006477: US-009507513-2106USA006479: US-009507513-2106USA006480: US-009507513-2106USA006481: US-009507513-2106USA006482: US-009507513-2106USA006483: US-009507513-2106USA006484: US-009507513-2106USA006485: US-009507513-2106USA006486: US-009507513-2106USA006487: US-009507513-2106USA006488: US-009507513-2106USA006489: US-009507513-2106USA006490: US-009507513-2106USA006491: US-009507513-2106USA006492: US-009507513-2106USA006493: US-009507513-2106USA006494: US-009507513-2106USA006495: US-009507513-2106USA006496: US-009507513-2106USA006497: US-009507513-2106USA006498:
Normal flu like symptoms, followed by injection site pain, sensitivity,  swelling, redness, itching, and firmness. The redness of the site has began 24 hours following injection and has continued to grow in size. All symptoms are presently happening.
pt exp a sz during which had an episode of incomprehensible speech following which pt walked into a wall & slumped to the floor;pt then had a 40-60 second episode of stiffening w/sl gen tonic clonic movements;loss of bowel & bladder;